| Document |
Document Title |
|
WO/2022/172135A1 |
Presented herein are integrated tube sheaths (tube sheaths) for implantable stimulation assemblies. An integrated tube sheath is configured to be disposed around, and is slideably engaged with, an outer surface of an associated stimulati...
|
|
WO/2022/171749A1 |
The present invention is directed to a urinary catheter kit comprising : - an aqueous lubricant composition comprising water and at least one polyether-polyurethane thermogelling copolymer P1, and - a urinary catheter with an external co...
|
|
WO/2022/169741A1 |
Described herein are compositions comprising a nitric oxide releasing material comprising a (i) a polysiloxane network and (ii) a plurality of nitric oxide-donating moieties covalently bonded to the polysiloxane network; and (b) a silico...
|
|
WO/2022/164971A1 |
Disclosed herein are liquid crystal-infused porous surfaces and methods of making and use thereof.
|
|
WO/2022/150498A1 |
Catheter securement compositions and methods providing significantly strong securement, water resistant seal, effective hemostasis, and antibacterial properties at and around vascular access sites. By securing the insertion site and the ...
|
|
WO/2022/146263A1 |
The novelty aspect of the invention is based on a drug delivery system that specifically carries and releases the active substance to the target organ or tissue. The invention particularly relates to coating of the shape memory component...
|
|
WO/2022/147091A1 |
Methods of modifying medical devices and medical devices are disclosed, One embodiment of a method of modifying a medical device includes functionalizing a surface of the medical device using cold plasma. One embodiment of a medical devi...
|
|
WO/2022/139081A1 |
Glaucoma is a kind of eye diseases caused by an increase of intraocular pressure (IOP). An increase in intraocular pressure damages the appearance and function of the optic nerve and, when lasting, results in vision loss. However, conven...
|
|
WO/2022/133973A1 |
Disclosed are methods of sterile filtration of a fibrinogen solution, the method being comprised of filtering the solution with one or more filters selected from a glass fiber pre-filter and an aseptic filter made of polysulfone or a der...
|
|
WO/2022/133483A1 |
Some examples of the disclosure are directed to medical balloon comprising a balloon base having an interior surface and an exterior surface, wherein the balloon base includes a base material (105), and one or more fibers (107) embedded ...
|
|
WO/2022/132628A1 |
The present disclosure relates to a kit for preventing, reducing, and/or treating surgical site infections, the kit comprising two or more antimicrobial components directed to two or more different post-surgical tissue depths in a subjec...
|
|
WO/2022/130737A1 |
A method for producing a chloroprene polymer composition which contains a chloroprene polymer, said method being equipped with a polymerization step for obtaining a polymer composition which contains a chloroprene polymer by polymerizing...
|
|
WO/2022/127631A1 |
The present invention provides a preparation method for an ultra-smooth porous surface for lubricating oil infusion of a medical catheter. The method comprises: obtaining a precursor solution containing a large number of immiscible dropl...
|
|
WO/2022/121328A1 |
The present invention relates to hydrophilic silicone rubber serving as a medical catheter, a preparation method therefor and an application thereof. The hydrophilic silicone rubber is obtained from nitrile-containing polysiloxane by mea...
|
|
WO/2022/114967A1 |
A device for implantation at a treatment site in the body of a patient for the removal of fluid from the treatment site. The device includes a conduit structure at least in part defining a fluid removal lumen, and a porous bioresorbable ...
|
|
WO/2022/115717A1 |
A method of manufacture of a subassembly for using in an aspiration catheter for removal of kidney stones from a patient is provided. The method comprises providing an elongate tubular structure for use as a vacuum shaft defining a vacuu...
|
|
WO/2022/105849A1 |
A drug-coated balloon and a preparation method therefor, the drug-coated balloon comprising a balloon body and a drug coating arranged on an outer surface of the balloon body, and the drug coating comprising a sequentially stacked bottom...
|
|
WO/2022/109301A1 |
Poly-lumenal catheters are taught in terms of making them, namely novel improved catheters are designed to deliver medicaments, particularly for radial access systems challenged by vasospasm, et seq. Membrane porosity is manufactured int...
|
|
WO/2022/103619A1 |
Catheter assemblies including an interfacial pH controller for maintaining hydration liquid pH are provided.
|
|
WO/2022/101518A1 |
The invention relates to a suspension for coating medical products, containing at least one tri-O-acylglycerol, at least one taxane in the form of microcrystals, and at least one solvent in which the at least one tri-O-acylglycerol disso...
|
|
WO/2022/101514A1 |
The invention relates to a suspension for coating medical products, containing at least one tri-O-acylglycerol, at least one limus-type agent in the form of microcrystals, and at least one solvent in which the at least one tri-O-acylglyc...
|
|
WO/2022/098661A1 |
Antigen-binding molecules (ABMs) that bind to Porphyromonas gingivalis are described. The ABMs may be human or humanized ABMs. The ABMs find use in treating infections involving P. gingivalis, such as periodontal disease. Also provided a...
|
|
WO/2022/086517A1 |
An inkjet ink that includes (A) a terpene phenol resin having a hydroxyl value of 10 to 80 mgKOH/g and (B) a carbonate ester whose boiling point is less than 150 °C. A printed article including the inkjet ink in dried form, and a method...
|
|
WO/2022/087060A1 |
Improved catheter systems featuring wrapped (not sintered) PTFE or WPTFE demonstrate unexpected flexibility with spaces and grooves, and feature these specialized liners to enable increased navigation into the neurovasculature through to...
|
|
WO/2022/040402A9 |
Stable formulations for a dimeric naphthalimide coating and preparation methods for forming said coating, dimeric naphthalimide coated articles, as well as sterilization and storage-stable packaging thereof.
|
|
WO/2022/074008A1 |
A therapeutic agent which inhibits cytokines and/or inflammatory mediators for use in the treatment of a patient affected by inflammation associated with atherosclerosis and/or a thrombotic state, wherein the treatment comprises the loca...
|
|
WO/2022/066831A1 |
A medical balloon includes a base balloon layer and at least one cellulose fiber applied to the base balloon layer, such as by an adhesive. The cellulose fiber may include hydro-dynamically focused, cellulose nano fibers. The cellulose f...
|
|
WO/2022/067358A1 |
The invention provides a coating method for coating a surface of a substrate material with a biosurfactant. The method includes the following steps: modifying the biosurfactant to promote its reactivity with a silane linker; oxidising th...
|
|
WO/2022/055079A1 |
The present invention relates to an airway management and endotracheal tube fixing device that can address issues of an existing airway management device and enables an endotracheal tube inserted into a patient's trachea to be firmly and...
|
|
WO/2022/048270A1 |
The present invention relates to a drug balloon and a preparation method therefor. The drug balloon comprises a balloon body and a coating provided on the surface of the balloon body; the coating sequentially comprises a bottom layer, a ...
|
|
WO/2022/039789A1 |
The present disclosure provides a food contact article. According to one embodiment, the food contact article includes at least one food contact surface. This at least one food contact surface is made up of at least 50 weight percent of ...
|
|
WO/2022/034452A1 |
The present invention relates to a medical device, a sterile urotip applicator made using specialized thermoplastic elastomers with high flexibility and elasticity for the safe and convenient distribution of precise topical anesthetic me...
|
|
WO/2022/033969A1 |
The present disclosure relates to stable formulations of tissue-type plasminogen activator (tPA). In particular, the disclosure relates to specific new formulations, methods of preparing them and methods of using them.
|
|
WO/2022/029252A1 |
In order to provide medical devices with a coating for local prophylaxis and treatment of unwanted cell proliferation and vascular constriction, a medical device having a coating on at least part of the surface that includes at least one...
|
|
WO/2022/031984A1 |
Methods including providing a block copolymer, the block copolymer comprising at least a polycaprolactone (PCL) block; and a second block being amorphous and having a glass transition temperature less than 30 °C; and subjecting the bloc...
|
|
WO/2022/023676A1 |
The invention relates to an imageable and resorbable medical device comprising at least one tubular portion (1) formed of a physical hydrogel of polysaccharides, capable of being inserted into the urethra of a subject, for various medica...
|
|
WO/2022/023416A1 |
This application relates generally to the field of materials and manufacturing methods involving single or multi-solvent, excipient and polymer-free drug coating formulations for production of microsphere coated drug delivery techniques.
|
|
WO/2022/016269A1 |
Pharmaceutical formulations and treatments are provided that make combined use of selected antibiotic cannabinoids with silver-containing medicaments. Therapeutically effective regimens are provided that facilitate positive drug-drug int...
|
|
WO/2022/014564A1 |
Provided is a cobalt-chromium alloy member suitable for use in a medical or aerospace device. According to the present invention, a cobalt-chromium alloy raw material comprises a composition containing, in terms of mass%, 23-32% of Ni, 3...
|
|
WO/2022/015755A1 |
A medical device comprising a surface, wherein a sulfanilamide is associated with the surface, and methods for making the same.
|
|
WO/2022/015749A1 |
Medical products containing hydration mediums, hydration mediums, and methods of making the same.
|
|
WO/2022/003619A1 |
A one-piece integrally moulded device includes a tubular part (2) having a distal end (5), a proximal end (4) and a hand grip (10). An inlet opening (3) at the proximal end allows drainage of urine through an outlet opening (6) at the di...
|
|
WO/2022/002483A1 |
A medical device assembly comprises a medical device, such as a urinary catheter, comprising an insertable part and a non-insertable part. The insertable part comprises an elongate shaft provided with a hydrophilic coating or surface. Th...
|
|
WO/2021/254507A1 |
The present invention relates to a drug-loaded medical device and a preparation method therefor, a drug balloon and a preparation method for a drug coating. The surface of the medical device or the drug balloon has a drug coating. The dr...
|
|
WO/2021/255441A1 |
The present invention provides a core-shell microparticle comprising a biodegradable polymer with at least two or more surface cavities for use in the treatment of vascular disease, wherein the shell further comprises one or more drugs. ...
|
|
WO/2021/254348A1 |
Disclosed are a super-lubricative coating for an interventional valve delivery system and a preparation method therefor. The super-lubricative coating comprises the following raw materials in parts by mass: 2.5 to 16.8 parts of an unsatu...
|
|
WO/2021/252137A1 |
Embodiments include a catheter comprising a proximal handle, a distal tip, and a shaft extending between the proximal handle and the distal tip. The shaft comprises an outer polymer layer, and an inner polymer layer disposed adjacent to ...
|
|
WO/2021/251695A1 |
The present invention relates to: a tube member having excellent local bendability, wherein bending only occurs freely in a specific area of a tube member at a working temperature, and thus, a user can adjust the bending angle of the tub...
|
|
WO/2021/247024A1 |
An implantable scaffold structure includes a biodegradable metallic scaffold; an inner non- biodegradable polymer coating conformally covering the scaffold; an outer coating formed of a biodegradable or non-biodegradable polymer, and hav...
|
|
WO/2021/242835A1 |
The present disclosure provides extruded PTFE composite tubes with a reduced coefficient of friction (COF). In some embodiments, such extruded PTFE composite tubes may exhibit a reduced change in coefficient of friction between about 20Â...
|
